Product NDC: | 0548-5900 |
Proprietary Name: | Cortrosyn |
Non Proprietary Name: | Cosyntropin |
Active Ingredient(s): | .25 mg/mL & nbsp; Cosyntropin |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0548-5900 |
Labeler Name: | Amphastar Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA016750 |
Marketing Category: | NDA |
Start Marketing Date: | 20030801 |
Package NDC: | 0548-5900-00 |
Package Description: | 10 VIAL in 1 CARTON (0548-5900-00) > 1 mL in 1 VIAL |
NDC Code | 0548-5900-00 |
Proprietary Name | Cortrosyn |
Package Description | 10 VIAL in 1 CARTON (0548-5900-00) > 1 mL in 1 VIAL |
Product NDC | 0548-5900 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cosyntropin |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20030801 |
Marketing Category Name | NDA |
Labeler Name | Amphastar Pharmaceuticals, Inc. |
Substance Name | COSYNTROPIN |
Strength Number | .25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenocorticotropic Hormone [Chemical/Ingredient],Adrenocorticotropic Hormone [EPC] |